AboujaoudeE, GamelN, KoranLM. Overview of kleptomania and phenomenological description of 40 patients. Prim Care Companion J Clin Psychiatry, 6:244–247. 2004.
2.
American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 4th(DSM-IV)Washington, DC: American Psychiatric Association, 1994.
3.
BayleFJ, CaciH, MilletB, RichaJ, OlieJP. Psychopathology and comorbidity of psychiatric disorders in patients with kleptomania. Am J Psychiatry, 160:1509–1513. 2003.
4.
BrewerJA, PotenzaMN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol, 75:63–75. 2008.
5.
DannonPN, LowengrubKM, IancuI, KotlerM. Kleptomania: comorbid psychiatric diagnosis in patients and their families. Psychopathology, 37:76–80. 2004.
6.
FeeneyDJ, KlykyloWM. Treatment for kleptomania. J Am Acad Child Adolesc Psychiatry, 36:723–724. 1997.
7.
GrantJE. Understanding and treating kleptomania: new models and new treatments. Isr J Psychiatry Relat Sci, 43:81–87. 2006.
8.
GrantJE, KimSW, OdlaugBL. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry, 65:600–606. 2009.
9.
GrantJE, OdlaugBL. Kleptomania: clinical characteristics and treatment. Rev Bras Psiquiatr, 30,Suppl 1:S11–S15. 2008.
10.
PrestaS, MarazzitiD, Dell'OssoL, PfannerC, PallantiS, CassanoGB. Kleptomania: Clinical features and comorbidity in an Italian sample. Compr Psychiatry, 43:7–12. 2002.
